Award

Delivery Order #SPE2DR26F3XVB

Delivery Order for Hydroxyzine HCl Tablets under AmerisourceBergen Pharmaceutical IDV

Buyer

Defense Logistics Agency

Award Amount

$6.71

Ceiling

$6.71

Awarded

March 11, 2026

Period of Performance

Mar 11, 2026 – Mar 12, 2026

Identifier

SPE2DR26F3XVB

NAICS

424210

This award represents a delivery order contract procured under an existing Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corporation, a leading pharmaceutical distribution company. The contract specifies the provision of Hydroxyzine HCl 25 mg tablets, a medication essential for various therapeutic uses, to fulfill agency pharmaceutical needs. The delivery order is a short-term, specific purchase within the broader multi-year IDV that AmerisourceBergen holds for supplying pharmaceutical products, underscoring the company's critical role in maintaining a reliable medication supply chain for federal health programs. The scope includes the timely delivery of the specified medication to the designated location in Conshohocken, Pennsylvania. This delivery order was awarded as a direct follow-on to the parent IDV contract, leveraging an existing competitive contract vehicle to ensure efficient procurement and continuity of service. The contract performance period is notably brief, reflecting its nature as a discrete delivery within the long-term pharmaceutical supply arrangement. Overall, this contract segment highlights the ongoing collaboration between the government and AmerisourceBergen to support healthcare logistics and public health through dependable pharmaceutical distribution.

Description

4571119083!HYDROXYZINE HCL 25 MG TABLET 100S

View original record